Loading clinical trials...
Loading clinical trials...
Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Cancer Institute (NCI)
NCT07404605 · MELANOMA, SKIN NEOPLASMS
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT05484570 · DNA Repair Disorder, Cockayne Syndrome, and more
NCT06938542 · Trisomy 13 Syndrome, Arthrogryposis Congenita Multiplex With Intestinal Atresia, and more
NCT06330324 · Ichthyosis, Palmoplantar Keratoses, and more
National Institutes of Health Clinical Center
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions